Title for MeetingAbstracts
Alphabetical listing of titles
Serum levels of soluble IL-2 receptor in HIV-1 infected patients.
Serum levels of soluble tumor necrosis factor (TNF) receptors correlate with the degree of subcutaneous adipocyte apoptosis in HIV-infected patients with lipodystrophy.
Serum Levels of Soluble Tumor Necrosis Factor (TNF) Receptors in HIV-Infected Patients with Antiretroviral-Associated Lipodystrophy.
Serum levels of stem cell factor are increased in asymptomatic HIV-infected patients and associated with prolonged survival.
Serum levels of TNF-alpha and IL-1 in HIV-1 infected i.v. drug users.
Serum levels of trimethoprim and sulfamethoxazole following a lower dose of co-trimoxazole in the treatment of Pneumocystis carinii pneumonia.
Serum levels of tumor necrosis factor-alpha and circulating intercellular adhesion molecule 1 of untreated and ZDV treated HIV-infected children.
Serum Lipids and Antitretroviral Therapy Among HIV-infected Men.
Serum lipids changes in HIV-infected patients under combination therapy containing a protease inhibitor.
Serum lipoprotein electrophoresis of HIV infected persons in Kolkata.
Serum markers of immune activation in HIV-associated pulmonary tuberculosis.
Serum Markers of Liver Fibrosis in HIV/HCV-infected Adults.
Serum myeloperoxidase in HIV infected children.
Serum neopterin (SN) and beta 2 microglobulin (B2M) in HIV disease monitoring.
Serum neopterin concentration in HIV infected IVDUs.
Serum neopterin levels in HIV-positive drug addicts of Bialystok district (Poland).
Serum neutrophil antibodies in children with HIV infection.
Serum paromomycin levels in AIDS patients treated for cryptosporidiosis.
Serum Pharmacokinetics of Pradofloxacin in Dogs after Multiple Oral Administrations at Various Dosages.
Serum Procalcitonin Accurately Rules out Bacteremia in Adult Patients with Acute Fever.
Serum prolactin levels in patients with human immunodeficiency (HIV) infection.
Serum Protease Inhibitor Level as a Marker of Adherence to HAART: Correlation with Self-Reported Adherence and with HIV RNA.
Serum RANTES as an early prognostic marker of HIV-1 disease progression.
Serum reactivity against HIV-1, HTLV-I and HTLV-II antibodies in rheumatic diseases.
Serum reactivity to HIV-1 neutralization epitopes: geographical diversity of binding activity and neutralization titre.
Serum reactivity to the HIV-1 endonuclease is directed to a unique antigenic site.
Serum Rifampicin Levels during Oral Antituberculous Therapy in HIV-negative Patients without Diarrhoea Compared with HIV-positive Patients with or without Diarrhoea in Zambia.
Serum sex hormone levels and body mass index in HIV infected women who have never used antiretroviral therapy.
Serum soluble CD30 as a predictor of prognosis in HIV-infected gay men.
Serum soluble CD8 molecule is a marker of immune activation and HIV pathogenesis.